P2.05. Clinical impact of TTF-1 for Combined Chemoimmunotherapy Efficacy in Lung Adenocarcinoma: A Multicenter Prospective Study - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yuki Katayama
Meta Tag
Speaker Yuki Katayama
Topic Metastatic NSCLC: Immunotherapy - Biomarker
multicenter study
TTF-1 expression
lung adenocarcinoma
progression-free survival
overall survival
objective response rate
PD-L1 expression
predictive factors
treatment decisions
Powered By